Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Moderna, inc. symbols : TAK save search
Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna
Published: 2022-05-31 (Crawled : 09:00) - biospace.com/
TAK | News | $13.35 -0.08% 230K
|
Health Technology
|
| O: -2.24%
H: 0.35%
C: -0.14%
MRNA | News S | $106.72 2.16% 510K
|
Health Technology
|
| O: 5.09%
H: 0.0%
C: 0.0%
covid-19 japan vaccine authorization
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
Published: 2022-05-31 (Crawled : 09:00) - biospace.com/
TAK | News | $13.35 -0.08% 230K
|
Health Technology
|
| O: -2.24%
H: 0.35%
C: -0.14%
MRNA | News S | $106.72 2.16% 510K
|
Health Technology
|
| O: 5.09%
H: 0.0%
C: 0.0%
covid-19 japan vaccine authorization
Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases
Published: 2021-07-22 (Crawled : 14:00) - prnewswire.com
TAK | News | $13.35 -0.08% 230K
|
Health Technology
|
| O: 0.3%
H: 0.24%
C: -0.53%
PFE | News A | $26.32 0.23% 4.4M
|
Health Technology
|
| O: 0.24%
H: 1.05%
C: 0.85%
JNJ | News | $148.24 -0.59% 1.6M
|
Health Technology
|
| O: -0.08%
H: 1.01%
C: 0.37%
SRNE | $0.015 140K
|
Health Technology
|
| O: -1.22%
H: 1.91%
C: -1.35%
MRNA | News S | $106.72 2.16% 510K
|
Health Technology
|
| O: -0.66%
H: 3.32%
C: 1.4%
BNTX | News | $89.015 1.14% 120K
|
Health Technology
|
| O: 3.83%
H: 5.33%
C: 4.24%
covid injection response infections
Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022
Published: 2021-07-20 (Crawled : 12:00) - biospace.com/
TAK | News | $13.35 -0.08% 230K
|
Health Technology
|
| O: 0.83%
H: 0.53%
C: -0.06%
MRNA | News S | $106.72 2.16% 510K
|
Health Technology
|
| O: 1.48%
H: 7.63%
C: -3.42%
covid vaccine
Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan Led by Takeda
Published: 2021-01-21 (Crawled : 15:00) - biospace.com/
TAK | News | $13.35 -0.08% 230K
|
Health Technology
|
| O: -0.97%
H: 0.62%
C: -0.63%
MRNA | News S | $106.72 2.16% 510K
|
Health Technology
|
| O: 0.11%
H: 9.36%
C: 6.15%
covid vaccine phase 3 phase 1 phase 2
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.94 84.57% 1.4M
|
CZOO | $8.77 75.75% 11M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
CMAX | $4.12 28.35% 65K
|
Manufacturing
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.